Sleep disease diagnosis testing is performed to diagnose and monitor the progression of sleep disease in the day to day life. Sleep testing involves detection of brain waves, blood oxygen level, heart rate and breathing pattern, and eye and leg movement. According to the National Commission on Sleep Disorders Research, approximately 40 million U.S. citizens suffer from chronic, long-term sleep disorders and a majority of this population experiences insomnia and obstructive sleep apnea.
This report tracks revenue generated through service providers by the sleep technician in laboratory/clinic, and home care setting. The report includes the revenue from technical fee as well as physician’s fee. This report covers the global sleep testing services market performance in terms of value contribution. It includes key trends, drivers, restraints, and opportunities influencing the growth of the global sleep testing services market over forecast period 2016–2021. Impact analysis of key growth drivers and restraints based on the weighted average model are included in this report to better equip clients with crystal clear decision-making insights. Global sleep testing services revenue is anticipated to increase to US$ 8,395.7 Mn by 2021, registering a CAGR of 12.9% during the forecast period.
The global sleep testing services market is segmented on the basis of:
On the basis of service type, the market is segmented as follows:
On the basis of end user, the market is segmented as follows:
By end user, the market is segmented into hospitals, sleep centers, and home care setting of which, the home care setting segment is expected to witness the highest CAGR of 15.7% during the forecast period.
On the basis of region/country, the market is segmented as follows:
Europe and Asia-Pacific markets are expected to gain 100 and 140 BPS respectively over the forecast period. However, North America market accounted for highest share in the global market in 2015 due to increasing trend of the shift to HST across North America, which is expected to reduce demand for in-lab testing.
Key features of this report
Sleep study/polysomnography is a type of test conducted to diagnose sleep disorders. Sleep study test records brain waves, oxygen level in blood, heart rate, and breathing, and eye and leg movements. A sleep study is usually conducted in a laboratory/clinic and in home care settings. A sleep study is conducted to diagnose various sleep disorder conditions such as sleep apnea, periodic limb movement disorder, narcolepsy, REM, sleep behavior disorder, unexplained chronic insomnia, and others. This study considers the revenue generated through sleep services conducted across clinics as well as in home care settings. The report also includes physician cost and out-of-pocket cost incurred by the patient. However, the report does not consider the cost of medication prescribed for the patient after diagnosis.
A sleep study is usually conducted in clinics and home care settings. In the U.S., a high cost of sleep testing is a matter of concern for patients undergoing sleep testing. As such, the sleep testing services market represent itself as one among the premium services in the healthcare sector, especially in the U.S. Thus, the overall cost of in-lab sleep testing services is substantially high in the U.S. The scenario is similar in the Australian market, as sleep testing services providers follow a similar cost pattern as the U.S. However, sleep testing services across European and Asian countries is quite affordable for patients. Hence, the sleep services market is expected to witness promising revenue growth in these regions.
On the basis of service type, the sleep testing services market is segmented into diagnostic services and treatment monitoring. Diagnostic sleep testing services is segmented into in-lab sleep testing and home sleep testing. In-lab sleep testing services segment is further sub-segmented into electroencephalogram, full polysomnography, CPAP/BiPAP Titration, Multiple Sleep Latency Test (MSLT), and maintenance of wakefulness test (MWT). In-lab sleep testing services accounted for largest revenue share in 2015 owing to higher adoption rate and premium pricing of services. Moreover, growing prevalence of sleep disorders and favorable reimbursement policies, as well as cover by private insurance services providers, are factors expected to fuel the growth of the global home sleep testing services market during the forecast period.
By sleep disease treatment monitoring, the market is sub-segmented into Obstructive Sleep Apnea, Insomnia, Restless Legs Syndrome, Circadian Rhythm Sleeping Disorders, narcolepsy, and Rapid Eye Movement (REM) sleep disorder. Obstructive sleep apnea is a highly prevalent sleep condition and accounted for major revenue share in the overall sleep disease treatment monitoring segment in 2015.
On the basis of the end user, the sleep testing services market is segmented into Hospitals, Sleep Centers, and Home Care Settings. Home Care setting segment is expected to create robust growth opportunities owing to lower cost and easy availability. However, in-lab sleep testing services segment is expected to remain dominant throughout the forecast period.
By region, the global sleep testing services market is segmented into North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. Europe and Asia Pacific regions are expected to exhibit strong growth potential owing to the availability of large patient pool and growing awareness regarding home based sleep testing. Moreover, medical tourism countries of Asia are expected benefit significantly by offering low-cost sleep services. Hence, these regions are expected to witness promising revenue growth from sleep services during the forecast period.
Some of the key sleep clinics profiled in the report are Midwest Sleep Services Inc., SleepMed Inc., SOVA Sleep Services Inc., Medical Service Company, Sleep Services Australia, Genesis SleepCare, St. Luke’s Center of Sleep Medicine, Total Sleep Holdings Plc., and Carolinas Sleep Services.
Some of the key sleep clinics profiled in the report: